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Hyaluronidase (HysA) is an important microbial enzyme that has medical importance. Hyaluronidase enzyme is 
produced by Staphylococcus aureus and is responsible for the spread of the organism during infection. A total of 85 clinical 
isolates of S. aureus were examined for hyaluronidase production. Strain of S. aureus S10 was associated with the highest 
productivity of hysA enzyme among the investigated isolates. The hysA gene was amplified from isolate S10 and S. aureus 
Newman by PCR method and cloned into the expression vector pRSET-B. The protein expression of the cloned hysA of  
S. aureus Newman (HysA-New protein) and S. aureus S10 (HysA-S10 protein) was performed in Escherichia coli BL21
and the optimum time for its expression was found to be 6 h after isopropyl-β-D-thiogalactoside (IPTG) induction.
Successful expression was confirmed by sodium dodecyl sulfate - polyacrylamide gel electrophoresis (SDS - PAGE) and
western blot analysis which showed a protein with a molecular mass of ~94 kDa. The expressed protein was concentrated by
size exclusion column with 30 MWCO and showed activity of 435 IU/ml and 401 IU/ml for hysA-S10 and hysA-S. aureus
Newman recombinant proteins, respectively. The activity of recombinant protein in the spent media of the transformed
E. coli BL21 was further analyzed under the effect of different pH, temperature and some chemical compounds.
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Introduction 
Hyaluronidase enzyme is capable of degrading 
hyaluronic acid (HA) which is an essential component 
of the extracellular matrix of human tissues1. 
Moreover, hyaluronic acid is a modulator to cellular 
immunity by elimination of inflammation and 
delaying allergic occurrences2. Hyaluronidases are 
produced by various organisms and have been found 
in both Gram-positive and Gram-negative bacteria. 
They have been implicated in a disease process as a 
way to invade and penetrate tissues3. Bacteria produce 
hyaluronidase to allow its spreading to deeper tissues 
so the infection becomes more virulent via hydrolysis 
of hyaluronic acid4. 
Staplylocuccus aureus is a main human pathogen 
that causes a variety of clinical infections5 and is also 
considered the major pathogen in nosocomial 
infections6. It produces numerous exoenzymes 
including DNAse, hyaluronidase, protease, lipase and 
collagenase. These enzymes have the ability to break 
host tissue hence bacterial propagation is stimulated 
and the potential of invasive diseases is increased7. 
Hyaluronidase is one of the most important factors in 
the virulence of S. aureus, whereas hyaluronidase 
breaks hyaluronic acid during infection and also it 
may represent a diagnostically significant 
characteristic for differentiating S. aureus from other 
members of this genus8. Also a previous study 
showed that mutation in hyaluronidase gene in S. 
aureus resulted in reduced virulence in a mouse 
abscess model9. 
Hyaluronidase enzyme was used therapeutically 
to enhance the diffusion of injected fluids especially 
local anaesthetics in ophthalmology10 also it 
was used with the chemotherapeutics. Additionally, 
hyaluronidase shows great role in treatment of joint 
diseases11. Moreover, in case of transplanted organ 
rejection hyaluronidases reduce oedema, and they can 
treat vitreous haemorrhage12. And also it has ability to 
enhance the penetration of cancer medications so 
chemotherapy-resistant tumors become more 
susceptible to treatment13. Therefore, production of 
hyaluronidase by recombinant protein expression 
would be of a great value due to its medical 
importance14. Recombinant hyaluronidase from 
Streptococcus pyogenes was successfully expressed in 









recombinant E. coli has been reported from 
Streptococcus pneumonia15. More recently, Abbasian 
et al16 produced the recombinant antigenic regions of 
hyaluronidase enzyme from Streptococcus pyogenes 
in E. coli. Therefore, the purpose of this study was to 
produce the recombinant hyaluronidase enzyme of  
S. aureus in E. coli as well as characterization of its 
activity at different physical conditions and in the 
presence of different compounds was investigated. 
 
Materials and Methods 
Microorganisms and Plasmids Used in this Study 
Eighty five isolates of S. aureus were collected from 
Mansoura University Hospitals, Dakhlia, Egypt. The 
isolates were obtained from different clinical sources; 9 
were isolated from sore throat, 20 were isolated from 
burn, 31 were isolated from wound infection, 11 were 
isolated from diabetic foot and 14 were isolated from 
nasal discharge. The isolates were purified and 
identified biochemically as S. aureus according to 
Laboratory Biochemical Standards17. S. aureus 
Newman was used as a reference strain (NCTC 8178). 
All bacterial strains were maintained at -80oC in brain 
heart infusion (BHI) broth medium containing 20% 
glycerol until further analyzes were performed. E. coli 
Top 10 (Thermofisher Scientific) was used as the 
primary host for plasmid clones, while E coli BL-21 
(DE3) (Invitrogen, USA) was used for protein 
expression. For recombinant protein production, the 
expression vector pRSET-B (Cat. No. V351-20, 
Invitrogen, USA) was used. Luria-Bertani (LB) 
medium, with or without 1.5% agar, was used for 
bacterial cultivation18. 
 
Screening for Hyaluronidase Production and Quantitative 
Estimation of its Level 
Screening of hyaluronidase production among 
clinical isolates was performed by hyaluronidase plate 
assay method which was described by Hart et al19 with 
minor modifications. Overnight cultures of the purified 
S. aureus strains in BHI broth medium were incubated 
at 37oC, for overnight with shaking at 200 rpm. 
Afterwards, the cultures were adjusted to the same OD 
630 nm (0.01 - 0.05) using fresh BHI broth. The 
culture (1 ml) was centrifuged at 8000 rpm for 5 min at 
4oC, and the supernatants containing the hyaluronidase 
enzyme (spent media) were filtered before storage at -
80oC until needed. Cups (7 mm diameter) were made 
in plates containing 1% agarose, 1% bovine serum 
albumin (BSA) and 0.1 mg/ml of HA (Sigma, H-
10504) in 0.3M sodium phosphate buffer (pH 5.3) and 
100 µl of spent media was applied into each well then 
the plates were incubated at 37oC for 24 h before 
flooding with 2M acetic acid. A background of opaque 
precipitated BSA conjugated to the undigested HA and 
their diameters were measured in millimeters. 
Hyaluronidase production was indicated by a clear 
zone that was visualized around the well due to 
degradation of HA that is present in the applied 
medium by hyaluronidase. The diameter of the clear 
zones (mm) was indication of the hyaluronidase 
activity. A standard curve was constructed in a separate 
plate by blotting different concentrations of standard 
hyaluronidase (Sanofi, 1500 IU) against the diameter 
of the corresponding clear zones as previously 
mentioned by Abdelkader et al20. The hyaluronidase 
activity in the spent medium of each isolate was 
measured and expressed as IU/ml by plotting the 
obtained clear zone on the standard curve of 
hyaluornidase and calculating the corresponding 
enzymatic activity. S. aureus (isolate S10) showed the 
highest level of hyaluronidase activity and was selected 
for production of recombinant hyaluronidase enzyme. 
 
Chromosomal DNA Isolation  
Genomic DNA was extracted from cultures of  
S. aureus Newman and S. aureus S10 strains according 
to the method described by El-Moafy et al21. Cell 
pellets were collected by centrifugation 5 ml of 
overnight bacterial culture at 13000 rpm for 5 min, then 
they were re-suspended in 200 µl breaking buffer 
[NaCl 100 mM, Tris HCl (pH 7.5, 0.5 M), triton 2%, 
EDTA (pH 8, 0.5 M) and SDS 1%] in addition to  
0.2 gm glass beads (0.25 - 0.5 mm) (Roth, Carlsruhe, 
Germany) and 200 µl of phenol: chloroform: isoamyl 
alcohol mix (25:24:1). The suspension was subjected to 
alternative intervals of vortexing (30 sec) and 
immersion in ice (30 sec) for a total of 10 min followed 
by mixing with 100 µl Tris-HCl (10 mM, pH 8). After 
that the suspension was centrifuged at 8000 rpm for  
5 min to remove the glass beads and the supernatant 
was transferred to clean Eppendorf tube. Genomic 
DNA was precipitated by addition of 1 ml absolute 
ethyl alcohol (Sigma, USA) followed by 
centrifugation. The supernatant was withdrawn and the 
DNA pellet was dissolved in 100 µl Tris HCl (10 mM, 
pH 8) and then stored at -20oC until further use. The 
concentration and purity of the DNA were measured 
via the Nano Drop spectrophotometer by measuring the 
absorbance at 260 nm. The purity of the DNA was 
determined by calculating the ratio of A260/280. Pure 
DNA has an A260/A280 ratio of 1.7 - 1.922. 





PCR was used to amplify hyaluronidase (hysA) 
gene of both S. aureus S10 and Newman using the 
following pair of primers; the forward primer   
(5'TCGCAAGGATCCGATGACATATAGAATAAAG
AAATGGC 3') contained BamH1 site and the Reverse 
primer (5'GACATTAAGCTTTTATTTAGTTAATTCA 
AAGTGCACGC3') contained recognition site for  
HindIII with Phusion high fidelity DNA polymerase 
as instructed by the manufacturer (NEB; UK).  
The following conditions were used for amplification: 
primary denaturation at 98oC for 30 sec followed  
by 35 cycles of: denaturation at 98oC for  
10 sec, annealing at 48oC for 30 sec and extension at 
72oC for 3 min and lastly a cycle of final extension at 
72oC for 10 min. The PCR product was analyzed by 
electrophoresis in 1.5% agarose gel in 1X TBE buffer 
and visualized by ethidium bromide staining on  
UV transilluminator. The PCR product was purified 
from agarose gel by QIA quick PCR purification kit 
(Cat No. 28104, Qiagen) as described as in the 
manufacturer's guidelines. 
 
Cloning of Hyaluronidase Gene in Expression Vector 
The purified PCR products and pRSET-B plamid  
were digested with BamHI and HindIII restriction 
enzymes. Then the digested PCR products were 
ligated into digested pRSET-B using T4 DNA ligase 
enzyme (NEB; UK) at 16°C overnight incubation. 
Moreover, E. coli Top10 and E. coli BL21 competent 
cells were prepared by calcium chloride method  
and then they were used for transformation of the 
constructed plasmids. E. coli BL21 was transformed 
with ligation product by heat shock method23. Fifty µl 
of chemically competent cells was transformed with 5 
µl ice-cooled plasmid or ligation products and left in 
ice for 30 min. Then this mixture was exposed to heat 
shock at 42°C for 1 min followed by immersion in ice 
for 2 min. LB medium was added to the transformed 
cells and incubated for 1 h with shaking at 37°C. Then 
centrifugation was done and the cell pellets were re-
suspended in 50 µl LB medium and grown on LB 
agar plates contained ampicillin (100 µg/ml) which 
allowed only the positive transformed cells to grow. 
Plasmids were isolated from the transformed cells 
using a Qiagen plasmid kit (Qiagen Inc.) and were 
confirmed for successful cloning by restriction 
digestion analysis. To confirm successful cloning of 
the hysA insert of S10 isolate in the correct 
orientation, the plasmid pl-HysA-S10 was sequenced 
using T7 promoter primer. 
Expression of Hyaluronidase from Transformed E. coli BL-21 
A colony of E. coli BL-21 which was transformed 
with pRSET-B harboring either the hysA ORF of  
S. aureus S10 (pl-hysA - S10 plasmid) or hysA of S. 
aureus Newman (pl-hysA-New plasmid) was cultured 
in 5 ml LB medium supplemented with ampicillin 
(100 µg/ml) at 37oC with agitation for 24 h. One ml of 
the overnight cultures of E. coli BL-21 which was 
transformed with either pl-hysA-new orpl-hysA- S10 
plasmids was used for inoculation of 50 ml LB broth 
containing ampicillin (100 µg/ml) and 1 mM IPTG 
followed by incubation at 37oC with 200 rpm shaking. 
Samples (1 ml) from each culture of E. coli  
BL-21 were collected in a period of 3-7 h intervals 
and were investigated for hyaluronidase production 
by the plate assay method with parallel measuring of 
OD 630 nm. Subculture of E. coli BL-21 which  
was transformed with empty vector was similarly 
prepared (negative control). For detection of HysA  
by SDS-PAGE, the 50 ml subcultures were harvested 
after 6 h of isopropyl β-D-1-thiogalactopyranoside 
(IPTG) induction. The spent media which contained 
the soluble recombinant protein were collected by 
centrifugation at 8000 rpm for 30 min at 4°C, then it 
was concentrated using size exclusion column with  
30 MWCO (Microsep Pall) at a speed of 4000 rpm till 
the final volume of the spent media reached to 150 µl. 
The concentrated proteins were analyzed by SDS-
PAGE (12%) 
 
Western Blot Analysis 
The expressed protein was analyzed by western 
blot analysis according to the method described by 
Mellick and Rodgers25 using diluted (1:1000)  
6-histidine epitope tag antibody (Sigma Aldrich) then 
visualization of the membrane by exposing it to 
tetramethylbenzidine (TMB; Sigma Aldrich) substrate 
solution at room temperature for few minutes to 
detect the target blotted HysA-S10 protein. 
 
Effect of the Physical and Chemical Factors on the Relative 
Activity of the Expressed HysA from E. Coli BL-21  
The effect of pH on the activity of the expressed 
HysA proteins (HysA-New and HysA-S10) in  
the spent media was measured in the range of pH  
(3-10). This was performed using citrate-sodium 
phosphate buffer (pH 3-7), phosphate buffer (pH 6-8) 
and NaOH-glycine buffer (pH 9-10)26. The spent 
media which were collected from sub-culturing  
of the transformed E. coli BL- 21 in LB medium 
contained ampicillin (100 µg/ml) and 1 mM IPTG  




for 6 h at 37oC with shaking were diluted with 10X  
of the investigated buffers then the activity of  
the enzyme was determined by plate assay method. 
On other hand the spent medium which was diluted 
(1:10) by sterile distilled water was used as a  
control and its HysA activity was considered as 100% 
activity. The activity of HysA at different pH  
values was calculated as a percent relative to  
such control. The activity of the expressed  
HysA proteins (HysA-New and HysA-S10) was  
also measured at different temperature. The spent 
media were diluted by 10X phosphate buffer (pH 6) 
and incubated at 4oC (control), 37oC, 40oC, 45oC, 
50oC, 55oC and 60oC for 1 h. The incubated spent 
media were analyzed for HysA activity by plate assay 
method. The HysA activity of the control that was 
incubated at 4oC was considered as 100% activity. 
The residual activity of HysA at different 
temperatures was calculated as a percent relative to 
such control. 
The effect of Ca2+, Mg2+, Mn2+, EDTA and urea on 
the activity of the expressed HysA proteins (HysA-
New and HysA-S10) was investigated. Each of these 
chemicals was included in the spent medium at a  
final concentration of 10, 50 and 100 mM followed  
by incubation at room temperature for 30 min. 
Afterwards, spent media were analyzed for HysA 
activity by plate assay method. The HysA activity of 
the control was considered a 100% activity. The 
activity of HysA enzyme in present of metal ion or 




Hyaluronidase Activity Among the Clinical S. aureus Isolates 
by Plate Assay 
Hyaluronidase production was detected in 82.3% 
(70 of 85) of examined S. aureus strains where  
as, they produced a zone of clearance (Fig. 1),  
while 15 isolates showed no hyaluronidase activity. 
Quantitative estimation of the hyaluronidase 
production was performed by hyaluronidase plate 
assay method. The hyaluronidase concentration was 
calculated using a standard curve, where the diameter 
of clearance zone was directly proportional to the 
logarithmic concentration of hysA enzyme. S. aureus 
isolate no. S10 (from burn) showed the highest level  
of hyaluronidase production (2511.89 IU/ml).  
S. aureus isolate (S10) was selected as a template for 
amplification of hyaluronidase gene and engineering 
of the recombinant vector. By investigation of the 
correlation between HysA production and the source 
of isolates, it was found that 7 out of 9 isolates from 
sore throat, 16 out of 20 isolates from burns, 26 out of 
31 isolates from wounds, 9 out of 11 isolates from 
diabetic foot and 12 out of 14 isolates from nasal 
mucosa were positive HysA producers. 
 
PCR and Cloning of Hyaluronidase Enzyme Gene 
The amplified gene of hyaluronidase enzyme from 
the genomic DNA of S. aureus Newman strain and 
S10 strain had the expected size of 2424 bp (Fig. 2A). 
PCR products were purified and cloned into 
expression vector pRSET-B after digestion of  
each of them with BamH1 and HindIII and  
then transformation occurred in E. coli Top 10. The 
positive clones were selected into LB/ampicillin agar. 
PCR reaction and digestion of recombinant plasmid 
from the selected clones by BamH1 and HindIII 
confirmed successful cloning of recombinant  
gene into E. coli Top 10. Also to confirm the 
transformation of pRSET-B-HysA in E. coli BL21, 
enzymatic digestion with BamHI and HindIII 
produced two bands at 2424 and 2900 bp representing 
the insert ORF of hyaluronidase, pRSET-B vector 
respectively (Fig. 2B). Moreover, sequencing showed 
that hysA insert of S10 isolate was inserted in the 
correct orientation in the plasmid pl-HysA-S10  
(Fig. 3). 
 
Expression of Recombinant Hyaluronidase Enzyme 
The expression of hyaluronidase (pRSET-B-hysA-




Fig. 1 — Screening of hyaluronidase activity of S. aureus 
representative isolates from various clinical sources using plate
assay method; S4 (burn), S10 (burn), S16 (burn), S23 (wound),
S26 (wound), S35 (wound), S50 (wound), S54 (nasal discharge),
S62 (nasal discharge), S70 (diabetic foot), S82 (sore throat). 
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Fig. 2 — Amplification of hyaluronidase gene and confirmation of the recombinant clones. (A) Agarose gel electrophoresis of 
the amplified hyaluronidase gene. Lane M:1 kbp DNA ladder. Lane 1: Amplified hysA from the S. aureus Newman genomic DNA. 
Lane 2: Amplified hysA from the S. aureus S10 genomic DNA, and lane 3: Negative control. (B) Agarose gel electrophoresis of the 
digestion of the plasmids isolated from recombinant clone.  M: 1 kbp ladder. Lanes 1, 2 and 3: BamHI/HindIII-digested pl-HysA-New, 
pl-HysA-S10 and pRSET-B empty vector respectively 
Fig. 3 — DNA sequence of pl-HysA-S10 obtained by T7 promoter primer: First codon of pRSET-B is indicated by yellow shading. The 
N-terminal His-tag is indicated by purple shading. First codon of hysA gene is indicated by green shading.
with 1 mM IPTG. Maximum protein expression was 
reported 6 h after incubation and the activity of 
recombinant protein was assayed and calculated as 
435 IU/ml for hysA-S10 and 401 IU/ml for hysA-
New per 1 ml of initial culture (Figs. 4 & 5; Table 1). 
SDS-PAGE analysis showed the molecular weight of 
94 kDa for recombinant protein (Fig. 6A). Also to 
confirm the identity of the protein western blot 
analysis was performed using anti-histidine tag 
monoclonal antibody (Sigma, Aldrich), where the 




recombinant hyaluronidase was detected as a clear 
band corresponding to its molecular mass (94 kDa) 
(Fig. 6B). 
 
The Effect of Physical Factors on the Activity of the Expressed 
HysA Proteins  
The optimum pH for the activity of HysA-New 
protein was found to be 6, where the relative activity 
increased by 20% in comparison with the 100% 
activity of the spent medium which diluted by sterile 
distilled water as demonstrated in Figure 7A. 
Similarly, the optimum pH for the activity of HysA-
S10 protein was at 6 and 7, however the relative 
activity increased by 50% as shown in Figure 7B. The 
residual activity of the protein in the spent media 
decreased gradually by increasing the temperature and 
was totally lost at temperature ≥ 50oC as shown in 
Figure 8A & B. 
 
The Effect of Chemical Factors (Metal Ions, EDTA and Urea) 
on the Activity of the Expressed HysA Proteins 
The effect of metals at different concentrations on 
the activity of the expressed HysA proteins was 
investigated. In case of HysA-New as demonstrated in 
Figure 9A, the relative activity of the protein was not 
affected at 10 and 50 mM CaCl2, although it was 
decreased at higher concentration (100 mM) of this 
metal. On the other side, the relative activity of the 
protein increased by 122% and 50% in the presence of 
MgSO4 (10 mM) and MnSO4 (10 mM), respectively, 
however the relative activity of HysA-New protein at 
higher concentrations (50, 100 mM) was decreased in 
case of MgSO4 or totally abolished in case of MnSO4. 
Regarding HysA-S10 protein, none of the metals at 
the investigated concentrations increased the relative 
activity of the protein. The relative activity of HysA-
S10 was maintained at 100% activity in case of CaCl2 
(10 mM), MgSO4 (10 and 50 mM). Incorporation  




Fig. 4 — Assay of HysA-New and HysA-S10 proteins in the spent
media of E. coli BL-21 after 3 - 7 h of IPTG induction. 3N, 4N,
5N, 6N and 7N: Spent media of HysA-New after 3 h, 4 h, 5 h, 6 h
and 7 h respectively. 3S, 4S, 5S, 6S and 7S: Spent media of
HysA-S10 after 3 h, 4 h, 5 h, 6 h and 7 h respectively. E: Spent
media of E. coli BL-21 transformed with pRSET-B after 6 h of




Fig. 5 — Time course screening of expression of HysA-New and
HysA-S10 by E. coli BL-21 after IPTG induction. Both curves
represent the average data from two independent experiments
(Mean ± SD). 
Table 1 — Activities of crude and recombinant hyaluronidase 
Strain S.aureus (S10) S.aureus Newman E. coli BL21/ pl-hysA-S10 E. coli BL21/ pl-hysA-new 
Hyaluronidase activity (IU/ml) 2511.89 510.5 435 401 
 
 
Fig. 6 — Analysis of  recombinant hyaluronidase  enzyme. 
A) Coomassie staining SDS-PAGE of the recombinant 
hyaluronidase protein. B) Western blot detection of recombinant
hyaluronidase. Lane M: Chromatein prestained protien ladder. 
Lane 1: The concentrated spent medium of the E. coli BL-21 
transformed by pRSET-B (negative control). Lane 2: The
concentrated spent medium of the E. coli BL-21 transformed by 
pRSET-B-HysA-S10. The expressed HysA-S10 in the 
concentrated spent medium of E. coli BL-21 is indicated by red 
arrows. 







Fig. 7 — The effect of pH on the relative activity of the expressed HysA in E. coli BL-21. A) Effect of pH on the activity of HysA-New 
protein. B) Effect of pH on the activity of HysA-S10 protein. Both charts represent the average data from two independent experiments 




Fig. 8 — The effect of temperature on the residual activity of the expressed HysA in E. coli BL-21. A) Influence of temperature on HysA-
New activity. B) Effect of temperature on HysA-S10 activity. Both charts represent the average data from two independent experiments 




Fig. 9 —  Effect of metal ions, EDTA and urea on the relative activity of expressed HysA in E. coli BL-21. A) The effect of Ca+2, Mg+2, 
Mn+2, EDTA and urea on the activity of HysA-New. B) The effect of Ca+2, Mg+2, Mn+2, EDTA and urea on the activity of HysA-S10. 
Both charts represent the average data from two independent experiments (Mean ± SD). The activity of HysA in the spent media diluted 
by both 10X phosphate buffer (pH 6) and sterile distilled water was considered 100% activity. 





relative activity by 32% in case of 10 mM 
concentration or totally inhibited the activity at 
concentrations 50 and 100 mM as shown in Figure 
9B. The relative activity of HysA-New protein (Fig. 
9A) was increased by 122% in the presence of urea  
(50 mM) however decreased by 32% by increasing 
the concentration of urea to 100 mM. In case of 
HysA-S10 protein (Fig. 9B), we found that the 
relative activity of the protein was decreased by 32% 
in the presence of urea (10 and 50 mM) however, it 
maintained its 100% in higher concentration  
(100 mM). Concerning EDTA, we observed that the 
relative activity of HysA-New remained 100% in the 
presence of EDTA (10 and 50 mM) but decreased by 
55% in case of EDTA (100 mM) (Fig. 9A). On the 
other hand, HysA-S10 relative activity was increased 
by 122% in the presence of EDTA (10 mM) and by 
50% in case of EDTA (50 and 100 mM) (Fig. 9B) 
 
Discussion 
The production of recombinant enzymes from 
bacteria for medical, analytical and industrial 
applications was taken great interest. Hyaluronidase 
enzyme has ability to degrade hyaluronic acid which 
is an essential component of connective tissue. 
Therefore, hyaluronidase might contribute directly in 
the invasion of microorganism and plays an important 
role in the pathogenesis of the bacterium by allowing 
greater microbial access to host tissue for 
colonization, also it plays a role in the migration of 
the organism between tissues27. Additionally, 
hyaluronidase may be an essential biofilm detaching 
agent owing to its ability for cell dispersal28-29. 
Numerous Gram-positive bacteria produced this 
enzyme such as Staphylococcus, Propionibacterium, 
Streptococcus spp., Clostridium, Peptostreptococcus 
and Streptomyces (Hynes & Waltan, 2000). 
Hyaluronidase enzyme is considered as a valuable 
tool for therapeutic purposes. Thus it can be used in 
some diseases treatment and diagnostic kits 
production30. Also hyaluronidase is considered 
important anti-tumor strategy31. This enzyme is not 
usually produced by its natural and main sources due 
to the low amount of product and also the risk of 
contamination. Therefore, research focused on the 
production of recombinant hysA enzyme in 
heterologous organisms. The production of 
recombinant hyaluronidase enzyme has been  
reported from various organisms, including 
Streptococcus pyogenes, Streptococcus pneumonia 
and Clostridium32. Few studies have focused on the 
production of hyaluronidase from S. aureus. Such 
reports were interested in either screening for 
hyaluronidase production by S. aureus or examination 
of its importance in the virulence of this bacterium. 
Also HysA gene was identified and sequenced in few 
studies33. 
In the present study, 85 clinical isolates of  
S. aureus were examined for production of 
hyaluronidase enzyme, whereas strains which 
produced a clear zone in the agar plate due to 
degradation of the present hyaluronic acid were 
identified as hyaluronidase enzyme producer (Fig. 1). 
It was found that 82.3% of the isolates produced 
hyaluronidase enzyme, so it is distributed widely 
among S. aureus isolates and this was consistent with 
previous studies that showed high percentage of 
hyaluronidase production among their S. aureus 
isolates34. Also this study indicated that the clinical 
source did not affect on the level of hyaluronidase 
production in S. aureus as the percent of 
hyaluronidase producing isolates were 77.77%, 80%, 
84%, 82% and 86% from sore throat, burns, wounds, 
diabetic foot and nasal discharge respectively.  
S. aureus isolate S10 from burn had the highest level 
of hyaluronidase production (2511.89 IU/ml). 
Due to pharmaceutical applications of 
hyaluronidase enzyme, we were interested in 
heterologous expression of bacterial hyaluronidase in 
E. coli BL-21. So in the present study, the expression 
of recombinant hyaluronidase enzyme from S10 
isolate and from standard S. aureus Newman using 
the expression vector pRSET-B was carried in E. coli 
BL21. E. coli is commonly used as a host for 
production of recombinant proteins in both industry 
and in research. In the following study BL-21strain of 
E. coli was used as host for expression, where as the 
absence of cytoplasmic proteases such as Deg P, Lon, 
HtpR and OmpT leads to increase in expression of 
hyaluronidase in E. coli BL2135. Mirjamali et al 
(2014) used pET system in which the hyaluronidase 
gene in under control of T7 promotor. But in our 
study expression of the gene of interest (hysA) which 
was present in pRSET-B was controlled by the strong 
T7 promotor and in E. coli BL21 transcription of the 
gene is performed by T7 RNA polymerase which is 
included in the genome of E. coli BL-21 under the 
control of this promoter and its expression is induced 
by IPTG (Sambrook et al, 2001). Once sufficient  
T7 RNA polymerase is produced, it binds to the  
T7 promotor and transcripts the target gene in the 
pRSET-B vector. So, in this system cellular factors 




which are involved in synthesis of protein did not 
affect on mRNA and protein production because the 
gene transcription system in this host cell did not 
depend on them. Therefore, in this system production 
is more than the systems in which protein synthesis 
depends on the host cell polymerases. However, HysA 
was previously expressed using different modified 
vector (Pnw21) and transformed into Staphylococcus 
carnosus37. Interestingly, hysA gene from both strains 
of S10 and S. aureus Newman was successfully 
expressed in E. coli BL21 with recombinant hysA 
enzyme maximum activity in the spent media was 
detected after 6 h of IPTG addition, whereas (Makris 
et al, 2004) reported that hyaluronidase specific 
activity was observed to increase rapidly during 
exponential growth and gradually decrease with  
time until approximately 24 h when activity was 
undetectable. The activity of recombinant hysA 
enzyme from S10 reached 435 IU/ml and from  
S. aureus Newman reached 401 IU/ml which were 
near to the activity of crude enzyme which was 
produced by the original S. aureus Newman (510.5 
IU/ml). The molecular mass of recombinant 
hyaluronidase was estimated to be 94 kDa by SDS 
PAGE which agreed with the size of the purified 
protein of the S. aureus 8325-4 hyaluronate lyase in 
(Farrell et al, 1995). 
The optimum pH for the activity of HysA was 
found to be 6. To make sure that the result of the 
optimum pH for activity of HysA-New and HysA-S10 
proteins is related only to the pH and not to the 
composition of the buffer, the activity of the 
expressed proteins at pH 6 and 7 was examined into 
two different buffers (citrate-sodium phosphate and 
phosphate buffers). Therefore, the investigation of the 
effect of other factors on the activity of the expressed 
proteins was performed at pH 6 using phosphate 
buffer. This was consistent with a previous study that 
showed that the optimum pH for the activity of HysA 
by Bacillus sp A50 was 6.5. Also it was found in this 
study there was a gradual loss in the activity by 
increasing temperature. However, we found that 
HysA-S10 was more stable than HysA-New, this was 
indicated by the percent residual activity at 40oC for 
HysA-New (45%) and HysA-S10 (67%). The activity 
of the expressed enzyme was totally lost after heating 
at 50oC for 1 h. However, a previous study showed 
that relative activity of hyaluronidase obtained from 
Bacillus sp A50 was not affected by heating at 45oC 
for 1 hr and 90% of the relative activity was totally 
lost by heating at 50oC for 1 hr. 
Additionally, in this study the effect of metal ions 
(Ca+2, Mg+2 and Mn+2), chelator (EDTA) and organic 
compound (urea) on the activity of both proteins was 
investigated at three different concentrations (10, 50 
and 100 mM). The relative activity of HysA-S10 was 
found to be not affected at a concentration 10 mM (in 
case of CaCl2 and MgSO4) or decreased in case of 
MnSO4. But the relative activity of HysA-New was 
increased at 10 mM concentration of MgSO4 (122% 
increase) and MnSO4 (50% increase). However, at 
higher concentration (50 and 100 mM) of these metals 
the relative activity was either greatly decreased or 
totally lost. But the relative activity of hyaluronidase 
from Bacillus sp A50 was increased up to 50% by 
increasing the concentration of CaCl2 up to 100 mM 
and it was increased also by 20% in the presence of 
100 mM MgSO4 (Guo et al, 2014). 
Concerning of the urea effect on the activity of the 
expressed HysA proteins, 50 mM concentration of 
urea increased the activity of HysA-New by 122%, 
while no increase in the relative activity of HysA-S10 
was observed in the presence of urea. In addition 
higher concentration of EDTA (100 mM) decreased 
the relative activity of HysA-New by 55%, while 
lower concentration of EDTA did not affect the 
relative activity of the protein. Interestingly, all the 
investigated concentrations of EDTA increased the 
relative activity of HysA-S10 protein, however the 
relative activity of hyaluronidase obtained  
from Bacillus sp A50 was decreased by incorporation 
of EDTA at concentrations of 10-100 mM  
(Guo et al, 2014). In conclusion, our present data 
indicates the successful cloning of hyaluronidase gene 
from S. aureus into E. coli and production of its 
recombinant enzyme in soluble and active form. 
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